| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bo Wei, Yiqin Xu, Ye Du, Jie Zhou, Fangfang Zhong, Chenglong Wu, Yiping Lo. Feasibility of Using Magnetic Resonance Spectroscopy Test Biomarkers to Diagnose Alzheimer's Disease: Systematic Evaluation and Meta-Analysis. Actas espanolas de psiquiatria. vol 52. issue 2. 2024-04-15. PMID:38622011. |
alzheimer's disease (ad) is the leading cause of dementia, resulting in impairments in memory, cognition, decision-making, and social skills. |
2024-04-15 |
2024-04-18 |
Not clear |
| Khushbu J Patel, David Yang, John R Best, Colleen Chambers, Philip E Lee, Alexandre Henri-Bhargava, Clark R Funnell, Dean J Foti, Jacqueline A Pettersen, Howard H Feldman, Haakon B Nygaard, Ging-Yuek R Hsiung, Mari L DeMarc. Clinical value of Alzheimer's disease biomarker testing. Alzheimer's & dementia (New York, N. Y.). vol 10. issue 2. 2024-04-10. PMID:38596484. |
in the investigating the impact of alzheimer's disease diagnostics in british columbia (impact-ad bc) study, we aimed to understand how alzheimer's disease (ad) cerebrospinal fluid (csf) biomarker testing-used in medical care-impacted medical decision-making (medical utility), personal decision-making (personal utility), and health system economics. |
2024-04-10 |
2024-04-12 |
Not clear |
| C G Cox, C R Salazar, A I Birnbaum, M Witbracht, S P Tam, G T Thai, S A Sajjadi, D L Gillen, J D Gril. Alzheimer's Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners. The journal of prevention of Alzheimer's disease. vol 11. issue 2. 2024-02-20. PMID:38374734. |
alzheimer's disease biomarker decision-making among patients with mild cognitive impairment and their care partners. |
2024-02-20 |
2024-02-22 |
Not clear |
| V Adarsh, G R Gangadharan, Ugo Fiore, Paolo Zanett. Multimodal classification of Alzheimer's disease and mild cognitive impairment using custom MKSCDDL kernel over CNN with transparent decision-making for explainable diagnosis. Scientific reports. vol 14. issue 1. 2024-01-20. PMID:38245656. |
multimodal classification of alzheimer's disease and mild cognitive impairment using custom mkscddl kernel over cnn with transparent decision-making for explainable diagnosis. |
2024-01-20 |
2024-01-23 |
Not clear |
| Randhir Dahiya, Nidhi Rani, Rajwinder Kaur, Geeta Chahal, Praveen Kumar, Gagandeep Kau. Exploring the Therapeutic Potential of Alkaloids in Alzheimer's Disease Management. Central nervous system agents in medicinal chemistry. 2024-01-12. PMID:38213138. |
alzheimer's disease (ad) is considered a gradual decline in memory, reasoning, decision-making, orientation to one's physical surroundings, and language. |
2024-01-12 |
2024-01-14 |
Not clear |
| Somayeh Shateri, Seyyed Hossein Khatami, Alireza Haghbin Toutounchi, Shima Rajaei, Meisam Mahdavi, Somayeh Mahmoodi Baram, Gholam-Ali Shahidi, Amir Hossein Habibi, Vajiheh Aghamollaii, Babak Ghlichnia, Lily Safakish, Alireza Doagoo, Farzaneh Salmani, Abbas Tafakhori, Aliasghar Keramatinia, Mohammad Reza Shahmohammadi, Saeed Karim. Plasma cytokines profile in patients with Alzheimer's and Parkinson's Disease: a comparative study in terms of inflammation. The International journal of neuroscience. 2023-12-15. PMID:38064237. |
alzheimer's disease (ad), the most prevalent form of dementia, is accompanied by progressive degradation of memory, decision-making, and judgment. |
2023-12-15 |
2023-12-17 |
Not clear |
| Charline Compagne, Hélène Trimaille, Magalie Bonnet, Lénaïc Ferrero, Éloi Magnin, Thomas Tanno. [Willingness to age in place and anosognosia of risks in Alzheimer's disease]. Geriatrie et psychologie neuropsychiatrie du vieillissement. vol 21. issue 3. 2023-12-14. PMID:38093573. |
alzheimer's disease leads to an alteration of decision-making abilities which may increase risk-taking behaviours, particularly associated anosognosia. |
2023-12-14 |
2023-12-17 |
Not clear |
| M Owen, N Bose, L Nisenbaum, K A Partrick, H M Filli. The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging. The journal of prevention of Alzheimer's disease. vol 10. issue 4. 2023-10-24. PMID:37874093. |
establishing a comprehensive arsenal of biomarkers will support strategic decision making and increase the likelihood of positive clinical trials and drug registration for the next generation of alzheimer's disease drugs targeting the biology of aging. |
2023-10-24 |
2023-11-08 |
human |
| Emily A Largent, Andrew Peterson, Jason Karlawis. Supported decision making: Facilitating the self-determination of persons living with Alzheimer's and related diseases. Journal of the American Geriatrics Society. 2023-09-12. PMID:37698156. |
supported decision making: facilitating the self-determination of persons living with alzheimer's and related diseases. |
2023-09-12 |
2023-10-07 |
Not clear |
| Gayatri Dev. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease. Frontiers in aging neuroscience. vol 15. 2023-09-04. PMID:37662550. |
to illustrate the clinical decision-making process, this study includes de-identified cases and reviews of the underlying etiology and pathology of alzheimer's and available therapies to exemplify diagnostic and treatment subtleties. |
2023-09-04 |
2023-09-07 |
Not clear |
| Jean O Taylor, Claire E Child, Rashmi K Sharma, Mary Grace Asirot, Lyndsey M Miller, Anne M Turne. Supportive care decision-making processes of persons with dementia and their caregivers. Dementia (London, England). 2023-09-01. PMID:37656956. |
this paper provides a description of findings from the decision-making in alzheimer's research project (dmar) investigating the process of decision-making about transitions to more supportive care. |
2023-09-01 |
2023-09-07 |
Not clear |
| Munire Aili, Kebing Zhou, Jun Zhan, Huaping Zheng, Feng Lu. Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease. Journal of materials chemistry. B. 2023-08-24. PMID:37615596. |
alzheimer's disease (ad) is a neurodegenerative disease that causes memory and cognitive dysfunction and reduces a person's decision-making and reasoning functions. |
2023-08-24 |
2023-09-07 |
Not clear |
| Olivia Greer, Rebekah Cheng, Lisa K Tamres, Meghan Mattos, Jonna L Morris, Melissa L Knox, Jennifer H Lingle. Nurse-led pre-test counseling for Alzheimer's disease biomarker testing: Knowledge and skills required to meet the needs of patients and families. Geriatric nursing (New York, N.Y.). vol 53. 2023-08-04. PMID:37540906. |
biomarker testing for alzheimer's disease and related disorders (adrd) brings new opportunities for nurses to foster shared decision-making by leading pre-test counseling (ptc) for patients and families. |
2023-08-04 |
2023-08-14 |
Not clear |
| Brent M Kiou. Medical Assistance in Dying in Neurology. Neurologic clinics. vol 41. issue 3. 2023-07-05. PMID:37407098. |
persons with conditions that cause cognitive impairment, such as alzheimer dementia, are often ineligible for maid, as their illness is not considered terminal in its early stages, whereas in later stages, they may have impaired decision-making capacity. |
2023-07-05 |
2023-08-14 |
Not clear |
| Kathy Y Liu, Nicolas Villain, Scott Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisett. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications. vol 5. issue 3. 2023-06-30. PMID:37389302. |
while amyloid-targeting immunotherapies may be promising disease-modifying alzheimer's disease treatments, rigorous and unbiased assessment of clinical trial data is critical to regulatory decision-making and subsequently determining their provision and utility in routine clinical practice. |
2023-06-30 |
2023-08-14 |
Not clear |
| Ashley Roach, Anita Hendrix Rogers, Susan L Mitchell, Ellen P McCarthy, Ruth Palan Lope. Staff and Proxy Views of Multiple Family Member Involvement in Decision Making for Nursing Home Residents With Advanced Dementia. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association. 2023-05-26. PMID:37235711. |
decision making for nursing home (nh) residents with alzheimer disease and related dementias often involves input from multiple family members and nh staff to address goals of care at the end of life. |
2023-05-26 |
2023-08-14 |
Not clear |
| Ashley Roach, Anita Hendrix Rogers, Susan L Mitchell, Ellen P McCarthy, Ruth Palan Lope. Staff and Proxy Views of Multiple Family Member Involvement in Decision Making for Nursing Home Residents With Advanced Dementia. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association. 2023-05-26. PMID:37235711. |
using data from the assessment of disparities and variation for alzheimer's disease nursing home care at end of life research study, a secondary analysis of qualitative data was conducted involving interviews of 144 nh staff and 44 proxies in 14 nhs to examine the perspectives of nh staff and proxies for nh residents with alzheimer disease and related dementias on the involvement of multiple family members in decision making about end-of-life care decisions. |
2023-05-26 |
2023-08-14 |
Not clear |
| Ashley Roach, Anita Hendrix Rogers, Susan L Mitchell, Ellen P McCarthy, Ruth Palan Lope. Staff and Proxy Views of Multiple Family Member Involvement in Decision Making for Nursing Home Residents With Advanced Dementia. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association. 2023-05-26. PMID:37235711. |
these findings suggest training and education is needed for nh staff to facilitate better communication with families and to support proxies in end-of-life decision making to address goals of care for nh residents with alzheimer disease and related dementias. |
2023-05-26 |
2023-08-14 |
Not clear |
| Janina Florack, Christina Abele, Stefanie Baisch, Simon Forstmeier, Daniel Garmann, Martin Grond, Ingmar Hornke, Tarik Karakaya, Jonas Karneboge, Boris Knopf, Gregor Lindl, Tanja Müller, Frank Oswald, Nathalie Pfeiffer, David Prvulovic, Aoife Poth, Andreas Reif, Irene Schmidtmann, Anna Theile-Schürholz, Heiko Ullrich, Julia Haberstro. Project DECIDE, part II: decision-making places for people with dementia in Alzheimer's disease: supporting advance decision-making by improving person-environment fit. BMC medical ethics. vol 24. issue 1. 2023-04-28. PMID:37118723. |
project decide, part ii: decision-making places for people with dementia in alzheimer's disease: supporting advance decision-making by improving person-environment fit. |
2023-04-28 |
2023-08-14 |
Not clear |
| Anne M Turner, Lyndsey M Miller, Mary Grace Asirot, Rashmi Sharm. Supporting decision making among people living with dementia: Developing a DCE tool. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 18 Suppl 2. 2022-12-20. PMID:36537498. |
the decision-making in alzheimer's research (dmar) project is developing a tool, informed by stakeholder input, that uses images, story-telling, and discrete choice experiments (dces) to unpack the preferences of plwd about transitions in supportive care and facilitate their inclusion in the decision-making process. |
2022-12-20 |
2023-08-14 |
Not clear |